Skip to main content
Fig. 1 | AAPS Open

Fig. 1

From: Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections

Fig. 1

Preparation of crushed Yomesan tablet for dissolution into Buffers. A Equate, Easy-Grip Pull Crusher, used to crush whole Yomesan (Niclosig and Lux) tablets. B 637.7 mg of a 500 mg niclosamide crushed Yomesan tablet (i.e., 0.784 mg niclosamide per 1 mg of tablet)

Back to article page